Atopic Dermatitis: Beyond the Itch that Rashes - 18/08/11
Doi : 10.1016/j.iac.2005.02.006
Mark Boguniewicz, MD a, b, ⁎ 
a Division of Pediatric Allergy-Immunology, Department of Pediatrics, National Jewish Medical and Research Center, 1400 Jackson Street, J 310, Denver, CO 80206, USA
b University of Colorado School of Medicine, Denver, CO, USA
*National Jewish Medical and Research Center 1400 Jackson Street, J 310, Denver, CO 80206
Résumé |
The prevalence of atopic dermatitis is increasing, and more than 50% of children with atopic dermatitis go on to develop asthma and allergies. A better understanding of the underlying immune abnormalities of this complex chronic relapsing skin disease is needed. Although the optimal treatment approach remains to be defined, several recent studies suggest a rationale for using topical calcineurin inhibitors as early intervention and adding topical corticosteroids as rescue therapy if needed.
Le texte complet de cet article est disponible en PDF.Plan
© 2005
Elsevier Inc. Tous droits réservés.
Vol 25 - N° 2
P. 333-351 - mai 2005 Retour au numéro
Article précédent
- Pediatric Sinusitis
- Michael Zacharisen, Ryan Casper
- Urticaria and Angioedema
- Sachin Baxi, Chitra Dinakar
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?